This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics

Register by January 24 to save up to $300

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan
Book Now
Menu
Book Now

Stefan Nilsson, Ph.D.
Founder at Lipigon Pharmaceuticals AB
Speaker

Profile

Stefan is the founder of Lipigon and was the CEO between 2016-2024. He was responsible for the biological approach of the Lipisense program, now in Phase II. Nilsson earned his PhD in blood lipids under Prof. Olivecrona at Umeå University and also holds an MBA.

Agenda Sessions

  • Reviving ANGPTL4 As a Drug Target with a GalNAc ASO Approach – A Case Study

    , 3:45pm
    View Session

At this event

Prev
Next
Dr. Christian Adam Olsen, PhD
Professor, Drug Design and Pharmacology
University of Copenhagen

See Stefan at TIDES Asia: Oligonucleotide & Peptide Therapeutics

Book Now